BIOMAT Database Logo BIOMAT Database Logo

Inhibition of maturational changes in Leydig cell function after treatment of rats with an agonist of luteinizing hormone releasing hormone [proceedings]. 1979

R M Sharpe, and H M Fraser

UI MeSH Term Description Entries
D007985 Leydig Cells Steroid-producing cells in the interstitial tissue of the TESTIS. They are under the regulation of PITUITARY HORMONES; LUTEINIZING HORMONE; or interstitial cell-stimulating hormone. TESTOSTERONE is the major androgen (ANDROGENS) produced. Interstitial Cells, Testicular,Leydig Cell,Testicular Interstitial Cell,Testicular Interstitial Cells,Cell, Leydig,Cell, Testicular Interstitial,Cells, Leydig,Cells, Testicular Interstitial,Interstitial Cell, Testicular
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D008297 Male Males
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012741 Sexual Maturation Achievement of full sexual capacity in animals and in humans. Sex Maturation,Maturation, Sex,Maturation, Sexual
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

R M Sharpe, and H M Fraser
Effect of luteinizing hormone-releasing factor on Leydig cell function.
January 1974, The Journal of clinical endocrinology and metabolism,
R M Sharpe, and H M Fraser
Stimulation of Leydig cell testosterone secretion in vitro and in vivo in hypophysectomized rats by an agonist of luteinizing hormone releasing hormone.
June 1982, Biochemical and biophysical research communications,
R M Sharpe, and H M Fraser
[Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist].
December 1990, Nihon Sanka Fujinka Gakkai zasshi,
R M Sharpe, and H M Fraser
Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist.
May 1979, Contraception,
R M Sharpe, and H M Fraser
Reciprocal inhibition of the long-acting luteinizing hormone releasing hormone agonist Buserelin and human chorionic gonadotropin in stimulating Leydig cell steroidogenesis.
December 1987, Journal of steroid biochemistry,
R M Sharpe, and H M Fraser
Dose-related inhibition of acute luteinizing hormone response during luteinizing hormone-releasing hormone agonist treatment for uterine leiomyoma.
February 1988, American journal of obstetrics and gynecology,
R M Sharpe, and H M Fraser
Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis.
February 1988, American journal of obstetrics and gynecology,
R M Sharpe, and H M Fraser
Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin.
June 1977, Biochemical and biophysical research communications,
R M Sharpe, and H M Fraser
Changes in the ovaries of rats after immunization against luteinizing hormone releasing hormone.
April 1978, The Journal of endocrinology,
R M Sharpe, and H M Fraser
Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
March 2003, The New England journal of medicine,
Copied contents to your clipboard!